Product cited in:
Evans, Ahmed, Bayliss et al.: "BRCA1, BRCA2 and CHEK2 c.1100 delC mutations in patients with double primaries of the breasts and/or ovaries." in: Journal of medical genetics, Vol. 47, Issue 8, pp. 561-6, 2010 (PubMed).
Monsees, Kraft, Chanock et al.: "Comprehensive screen of genetic variation in DNA repair pathway genes and postmenopausal breast cancer risk." in: Breast cancer research and treatment, Vol. 125, Issue 1, pp. 207-14, 2010 (PubMed).
Ho-Pun-Cheung, Assenat, Bascoul-Mollevi et al.: "A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancer." in: The pharmacogenomics journal, Vol. 11, Issue 6, pp. 437-43, 2011 (PubMed).
Konstantinova, Kadiyska, Sokolova et al.: "CHEK2 I157T and colorectal cancer in Bulgaria." in: Journal of B.U.ON. : official journal of the Balkan Union of Oncology, Vol. 15, Issue 2, pp. 314-7, 2010 (PubMed).
Guénard, Pedneault, Ouellette et al.: "Evaluation of the contribution of the three breast cancer susceptibility genes CHEK2, STK11, and PALB2 in non-BRCA1/2 French Canadian families with high risk of breast cancer." in: Genetic testing and molecular biomarkers, Vol. 14, Issue 4, pp. 515-26, 2010 (PubMed).